239 related articles for article (PubMed ID: 24341604)
1. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.
Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Dec; 12():450. PubMed ID: 24341604
[TBL] [Abstract][Full Text] [Related]
2. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
[TBL] [Abstract][Full Text] [Related]
3.
Zhao W; Li X; Yang Q; Zhou L; Duan M; Pan M; Qin Y; Li X; Wang X; Zeng W; Zhao H; Sun K; Zhu W; Afrane Y; Amoah LE; Abuaku B; Duah-Quashie NO; Huang Y; Cui L; Yang Z
Front Cell Infect Microbiol; 2022; 12():1015957. PubMed ID: 36310880
[TBL] [Abstract][Full Text] [Related]
4.
Agarwal P; Anvikar AR; Pillai CR; Srivastava K
Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015.
Diawara S; Madamet M; Kounta MB; Lo G; Wade KA; Nakoulima A; Bercion R; Amalvict R; Gueye MW; Fall B; Diatta B; Pradines B
Malar J; 2017 Mar; 16(1):118. PubMed ID: 28302108
[TBL] [Abstract][Full Text] [Related]
6. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
7. An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs.
Dery V; Duah NO; Ayanful-Torgby R; Matrevi SA; Anto F; Quashie NB
Malar J; 2015 Dec; 14():481. PubMed ID: 26625907
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.
Kwansa-Bentum B; Ayi I; Suzuki T; Otchere J; Kumagai T; Anyan WK; Osei JH; Asahi H; Ofori MF; Akao N; Wilson MD; Boakye DA; Ohta N
Malar J; 2011 Jul; 10():187. PubMed ID: 21745377
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
[TBL] [Abstract][Full Text] [Related]
10. Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.
Duah NO; Matrevi SA; de Souza DK; Binnah DD; Tamakloe MM; Opoku VS; Onwona CO; Narh CA; Quashie NB; Abuaku B; Duplessis C; Kronmann KC; Koram KA
Malar J; 2013 Oct; 12():377. PubMed ID: 24172030
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change.
Tinto H; Bonkian LN; Nana LA; Yerbanga I; Lingani M; Kazienga A; Valéa I; Sorgho H; Kpoda H; Guiguemdé TR; Ouédraogo JB; Mens PF; Schallig H; D'Alessandro U
Malar J; 2014 May; 13():207. PubMed ID: 24885950
[TBL] [Abstract][Full Text] [Related]
12. Temporal changes in Plasmodium falciparum anti-malarial drug sensitivity in vitro and resistance-associated genetic mutations in isolates from Papua New Guinea.
Koleala T; Karl S; Laman M; Moore BR; Benjamin J; Barnadas C; Robinson LJ; Kattenberg JH; Javati S; Wong RP; Rosanas-Urgell A; Betuela I; Siba PM; Mueller I; Davis TM
Malar J; 2015 Jan; 14():37. PubMed ID: 25626445
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
Quashie NB; Duah NO; Abuaku B; Koram KA
Ann Trop Med Parasitol; 2007 Jul; 101(5):391-8. PubMed ID: 17550644
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
15. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
Fall B; Pascual A; Sarr FD; Wurtz N; Richard V; Baret E; Diémé Y; Briolant S; Bercion R; Wade B; Tall A; Pradines B
Malar J; 2013 Mar; 12():107. PubMed ID: 23510258
[TBL] [Abstract][Full Text] [Related]
17. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
[TBL] [Abstract][Full Text] [Related]
19. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
